FATE THERAPEUTICS INC — Director's Dealing 2015

May 15, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FATE THERAPEUTICS INC (FATE)
CIK: 0001434316
Period of Report: 2015-05-13

Reporting Person: Coughlin Timothy P (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-05-13	Stock Option (right to buy)	$7.08	A	10000	Acquired	2025-05-12	Common Stock (10000)	Direct

Footnotes

F1: The shares subject to this option shall vest and become exercisable on the earlier of (i) May 13, 2016 or (ii) the date of the 2016 Annual Meeting of Stockholders, subject to the recipient's continued service on the Issuer's Board of Directors.

F2: Not applicable.